Skip to content

IM Cannabis Corp.

IMCC

CIK 0001792030 · Medicinal Chemicals & Botanical Products · Nasdaq

Revenue (TTM)
53.36M
+1.3% YoY FY Dec 2025
Net Income (TTM)
−26.33M
+0.2% YoY FY Dec 2025
EPS Diluted (TTM)
−4.83
−1.3% YoY FY Dec 2025
Gross Margin
18.6%
FY Dec 2025
Operating Margin
-19.9%
FY Dec 2025
Net Margin
-49.4%
FY Dec 2025
Free Cash Flow (TTM)
FY Dec 2025
Cash
2.73M
FY Dec 2025
Total Debt
FY Dec 2025
Shares Outstanding
5.89M sh
FY Dec 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings